Tate & Lyle | TATE - Ebitda

Aktienkurs
355.60
Täglich Wechseln
0.80 0.23%
Monatlich
-11.45%
Jährlich
-32.46%
Q1 Prognose
348.20




Ebitda Veränderung Datum
Agrana Beteiligungs EUR 20.4M 32.4M 2025-09
Anglo-eastern Plants USD 56.97M 18.92M 2024-12
Associated British Foods GBP 956M 136M 2022-12
Austevoll Seafood NOK 1.39B 735M 2025-12
Beiersdorf EUR 984M 147M 2025-06
British American Tobacco GBP 6.02B 200M 2024-06
Danone EUR 2.45B 149M 2025-06
Diageo GBP 3.53B 229M 2025-12
Givaudan CHF 778M 195M 2025-12
Glanbia EUR 289.7M 28.1M 2025-01
Henkel EUR 1.88B 139M 2024-12
Imperial Brands GBP 2.5B 703M 2025-12
International Flavors Fragrances USD 519M 33M 2025-09
Kerry EUR 635.8M 83.6M 2024-12
L'Oréal EUR 5.6B 587.6M 2025-06
Nestle CHF 9.09B 594M 2025-06
Nomad Foods EUR 142.7M 13.4M 2025-09
Ontex EUR 123.4M 13.6M 2024-12
Pernod Ricard EUR 2.18B 997M 2024-12
Premier Foods GBP 140.6M 49M 2025-03
Primary Health Properties ZAR 71.7M 700K 2024-12
Reckitt Benckiser GBP 1.95B 708M 2025-06
Tate & Lyle GBP 215M 22M 2025-12
Unilever EUR 6.6B 692M 2025-06